DAVID E. I. PYOTT - 29 Jun 2021 Form 4/A - Amendment Insider Report for PLIANT THERAPEUTICS, INC. (PLRX)

Role: Director
Signature: /s/ Mike Ouimette, attorney-in-fact
Issuer symbol: PLRX
Transactions as of: 29 Jun 2021
Net transactions value: $0
Form type: 4/A - Amendment
Filing time: 01 Jul 2021, 20:14:50 UTC
Date Of Original Report: 30 Jun 2021
Previous filing: 27 May 2021
Next filing: 19 Jul 2021
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PLRX	Stock Option (right to buy)	Award	$0	+13,286		$0.000000	13,286	29 Jun 2021	Common Stock	13,286	$28.20	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter following June 29, 2021 for three calendar quarters and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 29, 2021 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.

Content

25% of the shares subject to such option vest and become exercisable on the first day of each calendar quarter following June 29, 2021 for three calendar quarters and the remaining 25% of the shares subject to such option vest and become exercisable on the earlier of (i) the one-year anniversary of June 29, 2021 or (ii) the next annual meeting of the stockholders, subject to the Reporting Person's continued service to the Issuer as a director through each such date or, if earlier, such annual meeting.

Remarks:

This amendment is being filed solely to correct the expiration date previously reported for this option grant. All other information in the original Form 4 remains the same.